Six questions about Medicare’s proposed plan to cover digital therapeutics
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.
Medicare regulators’ proposal to start paying for some digital therapeutics products created a wave of enthusiasm when it was released earlier this month. Developers of software designed to treat medical conditions have struggled for a foothold in health care in part owing to challenges with reimbursement. So, getting the Centers for Medicare and Medicaid Services to pay for digital treatments is viewed as a pivotal milestone. Comments from key stakeholders about the Medicare proposal probably won’t start showing up in the docket for a few more weeks, but I’ve heard from many industry insiders.
Read Original Article: Six questions about Medicare’s proposed plan to cover digital therapeutics »
